What is Bold Therapeutics worth?
$140.0Mlast known valuation
Bold Therapeutics last raised $5.5M in its Early Stage VC (Jul 2018).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Bold Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2018 | Early Stage VC | $5.5M | ▮ | ▮ |
How Bold Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bold Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Bold Therapeutics worth?
- Bold Therapeutics's last known valuation is $140.0M.
- How much has Bold Therapeutics raised?
- Bold Therapeutics has raised $25.0M in total funding across 1 recorded rounds.
- When did Bold Therapeutics last raise?
- Bold Therapeutics last raised in Jul 2018 (Early Stage VC), raising $5.5M.